TITAN PHARMACEUTICALS INC (TTNP) Nonoperating Income (Expense) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Titan Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2024.
  • Titan Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $3 K, a 86.4% decline year-over-year.
  • Titan Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $1.69 M, a 3148% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was $1.71 M, a 5790% increase from 2022.
  • Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $29 K, a 95% decline from 2021.
  • Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was $578 K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.69 M $3 K -$19 K -86.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.71 M -$39 K -$84 K -187% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.79 M $1.72 M +$1.72 M +34360% Jul 1, 2023 Sep 30, 2023 10-K 2024-04-01
Q2 2023 $74 K $2 K +$22 K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $52 K $22 K +$23 K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $29 K $45 K +$96 K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$67 K $5 K +$12 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$79 K -$20 K -$665 K -103% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $586 K -$1 K +$8 K +88.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $578 K -$51 K -$1.87 M -103% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.45 M -$7 K +$252 K +97.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.2 M $645 K +$902 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.29 M -$9 K +$1.35 M +99.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$56 K $1.82 M +$1.97 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$2.02 M -$259 K -$1.34 M -124% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$682 K -$257 K +$58 K +18.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$740 K -$1.36 M -$1.13 M -485% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $386 K -$147 K +$91 K +38.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $295 K $1.08 M +$1.17 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$878 K -$315 K -$85 K -37% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$793 K -$232 K -$34 K -17.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$759 K -$238 K +$48 K +16.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$807 K -$93 K +$28 K +23.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$835 K -$230 K -$400 K -235% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$435 K -$198 K -$630 K -146% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $195 K -$286 K -$1.21 M -131% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 $1.41 M -$121 K -$117 K -2925% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.53 M $170 K +$286 K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.24 M $432 K +$447 K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $792 K $927 K +$971 K Oct 1, 2016 Dec 31, 2016 10-K/A 2019-04-02
Q3 2016 -$179 K -$4 K +$1 K +20% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$180 K -$116 K +$1.07 M +90.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$1.25 M -$15 K +$3.27 M +99.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$4.52 M -$44 K -$824 K -106% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-02
Q3 2015 -$3.7 M -$5 K -$1.46 M -100% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$2.24 M -$1.19 M -$897 K -307% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$1.34 M -$3.28 M -$2.41 M -277% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.07 M $780 K +$347 K +80.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $725 K $1.45 M +$2.47 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$1.75 M -$292 K -$5.65 M -105% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $3.9 M -$870 K -$6.7 M -115% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $10.6 M $433 K +$5.58 M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $5.02 M -$1.02 M -$968 K -1976% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $5.99 M $5.36 M +$5.34 M +35607% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $651 K $5.83 M +$7.46 M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$6.81 M -$5.15 M -$3.01 M -141% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-31
Q3 2012 -$3.8 M -$49 K -$1.2 M -104% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$2.6 M $15 K +$2.8 M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$5.4 M -$1.63 M -$702 K -75.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$4.7 M -$2.13 M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-31
Q3 2011 $1.15 M +$1.4 M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$2.79 M -$2.67 M -2224% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$929 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$249 K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$120 K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.